Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 15, 2008 - Issue 5-6
11
Views
1
CrossRef citations to date
0
Altmetric
Regular Articles

31P Magnetic Resonance Spectroscopy of Endothelial Cells Grown in Three-Dimensional Matrigel Constructs as an Enabling Platform Technology: II. The Effect of Anti-Inflammatory Drugs on Phosphometabolite Levels

, , , &
Pages 299-307 | Received 09 Jul 2008, Accepted 07 Sep 2008, Published online: 13 Jul 2009

REFERENCES

  • Bouchard J. F., Lamontagne D. Mechanisms of protection afforded by cyclooxygenase inhibitors to endothelial function against ischemic injury in rat isolated hearts. Journal of Cardiovascular Pharmacology 1999; 34: 755–763
  • Boulanger Y., Labelle M., Khiat A. Role of phospholipase A(2) on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases. Brain Research Brain Research Reviews 2000; 33: 380–389
  • Chrobak K. M., Potter D. R., Tien J. Formation of perfused, functional microvascular tubes in vitro. Microvascular Research 2006; 71: 185–196
  • Constantinidis I., Sambanis A. Noninvasive monitoring of tissue-engineered constructs by nuclear magnetic resonance methodologies. Tissue Engineering 1998; 4: 9–17
  • Constantinidis I., Simpson N. E., Grant S. C., Blackband S. J., Long R. C., Jr., Sambanis A. Non-invasive monitoring of tissue-engineered pancreatic constructs by NMR techniques. Advances in Experimental Medicine and Biology 2006; 585: 261–276
  • Dahan A., Duvdevani R., Dvir E., Elmann A., Hoffman A. A novel mechanism for oral controlled release of drugs by continuous degradation of a phospholipid prodrug along the intestine: In-vivo and in-vitro evaluation of an indomethacin-lecithin conjugate. Journal of Controlled Release 2007; 119: 86–93
  • Dvir E., Friedman J. E., Lee J. Y., Koh J. Y., Younis F., Raz S., Shapiro I., Hoffman A., Dahan A., Rosenberg G., Angel I., Kozak A., Duvdevani R. A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl-sn-glycero-3-phosophatidyl [corrected] choline], shows superior safety and similar efficacy in reducing brain amyloid beta in an Alzheimer's disease model. Journal of Pharmacology and Experimental Therapeutics 2006; 318: 1248–1256
  • Fallbrook A., Turenne S. D., Mamalias N., Kish S. J., Ross B. M. Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity. Brain Research 1999; 834: 207–210
  • Gloria M. A., Cenedeze M. A., Pacheco-Silva A., Câmara N. O. The blockade of cyclooxygenases-1 and -2 reduces the effects of hypoxia on endothelial cells. Braz J Medical and Biological Research 2006; 39: 1189–1196
  • Glunde K., Ackerstaff E., Mori N., Jacobs M. A., Bhujwalla Z. M. Choline phospholipid metabolism in cancer: Consequences for molecular pharmaceutical interventions. Molecular Pharmaceutics 2006; 3: 496–506
  • He T., Lu T., d'Uscio L. V., Lam C. F., Lee H. C., Katusic Z. S. Angiogenic function of prostacyclin biosynthesis in human endothelial progenitor cells. Circulation Research 2008; 103: 80–88
  • Jacobsohn D. A., Vogelsang G. B. Acute graft versus host disease. Orphanet Journal of Rare Diseases 2007; 2: 35
  • Jones R., Rubin G., Berenbaum F., Scheiman J. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs. American Journal of Medicine 2008; 121: 464–474
  • Kawai S., Nishida S., Kato M., Furumaya Y., Okamoto R., Koshino T., Mizushima Y. Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. European Journal of Pharmacology 1998; 347: 87–94
  • Kirkpatrick C. J., Krump-Konvalinkova V., Unger R. E., Bittinger F., Otto M., Peters K. Tissue response and biomaterial integration: The efficacy of in vitro methods. Biomolecular Engineering 2002; 19: 211–217
  • Kumar R., Billimoria J. D. Gastric ulceration and the concentration of salicylate in plasma in rats after administration of 14C-labelled aspirin and its synthetic triglyceride 1,3-dipalmitoyl-2(2′-acetoxy-[14C]carboxylbenzoyl) glycerol. Journal of Pharmaceutics and Pharmacology 1978; 30: 754–758
  • Lambert D. M. Rationale and applications of lipids as prodrug carriers. European Journal of Pharmaceutical Sciences 2000; 11(Suppl 2)S1527
  • Levenberg S. Engineering blood vessels from stem cells: Recent advances and applications. Current Opinion in Biotechnology 2005; 16: 516–523
  • Lichtenberg A., Tudorache I., Cebotari S., Suprunov M., Tudorache G., Goerler H., Park J. K., Hilfiker-Kleiner D., Ringes-Lichtenberg S., Karck M., Brandes G., Hilfiker A., Haverich A. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 2006; 114(1 suppl)I559–I565
  • Lumelsky N. L. Commentary: Engineering of tissue healing and regeneration. Tissue Engineering 2007; 13: 1393–1398
  • Methe H., Nugent H. M., Groothuis A., Seifert P., Sayegh M. H., Edelman E. R. Matrix embedding alters the immune response against endothelial cells in vitro and in vivo. Circulation 2005; 112: I89–I95
  • Mondrinos M. J., Koutzaki S. H., Poblete H. M., Crisanti M. C., Lelkes P. I., Finck C. M. In vivo pulmonary tissue engineering: Contribution of donor-derived endothelial cells to construct vascularization. Tissue Engineering 2008; 14: 361–368
  • Murakami M., Kudo I. Phospholipase A2. Journal of Biochemistry 2002; 131: 285–292
  • Nikkola L., Seppala J., Harlin A., Ndreu A., Ashammakhi N. Electrospun multifunctional diclofenac sodium releasing nanoscaffold. Journal of Nanoscience and Nanotechnology 2006; 6: 3290–3295
  • Prabaharan M., Rodriguez-Perez M. A., de Saja J. A., Mano J. F. Preparation and characterization of poly(l-lactic acid)-chitosan hybrid scaffolds with drug release capability. Journal of Biomedicine and Material Research B Applied Biomaterials 2007; 81: 427–434
  • Reynolds E. F. Martindale—The Extra Pharmacopoeia. The Pharmaceutical Press, London 1982
  • Rodriguez-Tellez M., Arguelles F., Herrerias J. M., Jr., Ledro D., Esteban J., Herrerias J. M. Antiinflamatory agents less dangerous for gastrointestinal tract. Current Pharmaceutical Design 2001; 7: 951–976
  • Schmidt D., Asmis L. M., Odermatt B., Kelm J., Breymann C., Gössi M., Genoni M., Zund G., Hoerstrup S. P. Engineered living blood vessels: Functional endothelia generated from human umbilical cord-derived progenitors. Annals of Thoracic Surgery 2006; 82: 1465–1471
  • Schneider B. L., Schwenter F., Pralong W. F., Aebischer P. Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery. Molecular Therapy 2003; 7: 506–514
  • Sterin M., Cohen J. S., Ringel I. Hormone sensitivity is reflected in the phospholipid profiles of breast cancer cell lines. Breast Cancer Research and Treatment 2004; 87: 1–11
  • Sterin M., Ringel I., Lecht S., Lelkes P. I., Lazarovici P. 31P magnetic resonance spectroscopy of endothelial cells grown in three-dimensional Matrigel construct as an enabling platform technology: I. The effect of glial cells and valproic acid on phosphometabolite level. Endothelium 2008, this issue
  • Sugihara J., Furuuchi S., Ando H., Takashima K., Harigaya S. Studies on intestinal lymphatic absorption of drugs. II. Glyceride prodrugs for improving lymphatic absorption of naproxen and nicotinic acid. Journal of Pharmacobiodynamics 1988; 11: 555–562
  • Suleyman H., Demircan B., Karagoz Y. Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacological Reports 2007; 59: 247–258
  • Suuronen E. J., Muzakare L., Doillon C. J., Kapila V., Li F., Ruel M., Griffith M. Promotion of angiogenesis in tissue engineering: Developing multicellular matrices with multiple capacities. International Journal of Artificial Organs 2006; 29: 1148–1157
  • Takel T., Sakai S., Ono T., Ijima H., Kawakami K. Fabrication of endothelialized tube in collagen gel as a starting point for self-developing capillary-like network to construct three-dimensional organs in vitro. Biotechnology and Bioengineering 2006; 95: 1–7
  • Terrovitis J. V., Bulte J. W., Sarvananthan S., Crowe L. A., Sarathchandra P., Batten P., Sachlos E., Chester A. H., Czernuszka J. T., Firmin D. N., Taylor P. M., Yacoub M. H. Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering. Tissue Engineering 2006; 12: 2765–2775
  • Tosti E., Dahl L., Endresen M. J., Henriksen T. Endothelial degradation of extracellular lyso-phosphatidylcholine. Scandinavian Journal of Clinical and Laboratory Investigations 1999; 59: 249–257
  • Wilhelmi M. H., Mertsching H., Wilhelmi M., Leyh R., Haverich A. Role of inflammation in allogeneic and xenogeneic heart valve degeneration: Immunohistochemical evaluation of inflammatory endothelial cell activation. Journal of Heart Valve Diseases 2003; 12: 520–526
  • Yu X. X., Wan C. X., Chen H. Q. Preparation and endothelialization of decellularised vascular scaffold for tissue-engineered blood vessel. Journal of Materials Science: Materials in Medicine 2008; 19: 319–326

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.